JP2007515431A5 - - Google Patents

Download PDF

Info

Publication number
JP2007515431A5
JP2007515431A5 JP2006545655A JP2006545655A JP2007515431A5 JP 2007515431 A5 JP2007515431 A5 JP 2007515431A5 JP 2006545655 A JP2006545655 A JP 2006545655A JP 2006545655 A JP2006545655 A JP 2006545655A JP 2007515431 A5 JP2007515431 A5 JP 2007515431A5
Authority
JP
Japan
Prior art keywords
formula
compound
disease
group
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006545655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007515431A (ja
JP4846596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/038233 external-priority patent/WO2005066161A1/en
Publication of JP2007515431A publication Critical patent/JP2007515431A/ja
Publication of JP2007515431A5 publication Critical patent/JP2007515431A5/ja
Application granted granted Critical
Publication of JP4846596B2 publication Critical patent/JP4846596B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006545655A 2003-12-19 2004-12-08 三環系のステロイドホルモン核内受容体モジュレータ Expired - Fee Related JP4846596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53128303P 2003-12-19 2003-12-19
US60/531,283 2003-12-19
PCT/US2004/038233 WO2005066161A1 (en) 2003-12-19 2004-12-08 Tricyclic steroid hormone nuclear receptor modulators

Publications (3)

Publication Number Publication Date
JP2007515431A JP2007515431A (ja) 2007-06-14
JP2007515431A5 true JP2007515431A5 (cg-RX-API-DMAC7.html) 2008-01-24
JP4846596B2 JP4846596B2 (ja) 2011-12-28

Family

ID=34748755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545655A Expired - Fee Related JP4846596B2 (ja) 2003-12-19 2004-12-08 三環系のステロイドホルモン核内受容体モジュレータ

Country Status (21)

Country Link
US (1) US7803814B2 (cg-RX-API-DMAC7.html)
EP (1) EP1697350B1 (cg-RX-API-DMAC7.html)
JP (1) JP4846596B2 (cg-RX-API-DMAC7.html)
CN (1) CN1918151A (cg-RX-API-DMAC7.html)
AR (1) AR046951A1 (cg-RX-API-DMAC7.html)
AT (1) ATE399163T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004312293A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416882A (cg-RX-API-DMAC7.html)
CA (1) CA2549053C (cg-RX-API-DMAC7.html)
CY (1) CY1108309T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004014640D1 (cg-RX-API-DMAC7.html)
DK (1) DK1697350T3 (cg-RX-API-DMAC7.html)
ES (1) ES2308296T3 (cg-RX-API-DMAC7.html)
IL (1) IL175996A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06007055A (cg-RX-API-DMAC7.html)
NO (1) NO20063329L (cg-RX-API-DMAC7.html)
PL (1) PL1697350T3 (cg-RX-API-DMAC7.html)
PT (1) PT1697350E (cg-RX-API-DMAC7.html)
SI (1) SI1697350T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005066161A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200604889B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400816A (en) * 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
EP1838672B1 (en) * 2004-12-23 2015-02-18 Athersys, Inc. 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
US8034940B2 (en) 2006-08-09 2011-10-11 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
ES2375877T3 (es) 2006-10-31 2012-03-07 Pfizer Products Inc. Compuestos de pirazolina como antagonistas de receptores de mineralocorticoides.
TWI431010B (zh) 2007-12-19 2014-03-21 Lilly Co Eli 礦皮質素受體拮抗劑及使用方法
ES2370148T3 (es) * 2008-01-11 2011-12-13 Eli Lilly & Company (e)-n-{3-[fluoro-11h-10-oxa-1-aza-dibenzo-[a,d]-ciclohepten-5-iliden)-propil]-fenil}-metilsulfonamida como modulador del receptor de glucocorticoides para el tratamiento de artritis reumatoide.
JPWO2010001990A1 (ja) * 2008-07-03 2011-12-22 協和発酵キリン株式会社 四環系化合物
WO2010104721A1 (en) 2009-03-12 2010-09-16 Eli Lilly And Company Mineralocorticoid receptor antagonist and methods of use
WO2011081173A1 (ja) * 2009-12-29 2011-07-07 協和発酵キリン株式会社 四環系化合物
EP2568986B1 (en) 2010-05-10 2016-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
EP2582365B1 (en) 2010-06-16 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions for stimulating reepithelialisation during wound healing
EP2638012A1 (en) 2010-11-10 2013-09-18 Boehringer Ingelheim International GmbH Pyridyl ureas as mineralocorticoid receptor antagonists
KR20140051998A (ko) * 2011-08-03 2014-05-02 교와 핫꼬 기린 가부시키가이샤 디벤조옥세핀 유도체
CN116783181B (zh) * 2021-04-12 2026-01-30 上海瑛派药业有限公司 取代的稠合双环类化合物作为parp抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2603713B1 (fr) * 1986-09-10 1992-07-24 Canon Kk Derive nouveau de 5h-dibenzo(a,d)cycloheptane-(ene)ylidene, son procede de production et support electrophotographique photosensible le contenant
JPH01161245A (ja) 1987-12-18 1989-06-23 Canon Inc 電子写真感光体
US4999363A (en) * 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US5093210A (en) * 1989-06-30 1992-03-03 Ricoh Company, Ltd. Electroluminescent device
JPH0446352A (ja) 1990-06-14 1992-02-17 Minolta Camera Co Ltd 感光体
US6372779B1 (en) * 1997-12-29 2002-04-16 Ortho Pharmaceutical Corporation Anti-inflammatory compounds
EP1154997A4 (en) 1999-01-26 2002-11-04 Dana Farber Cancer Inst Inc PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
US7087636B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
JP2006508893A (ja) 2002-03-15 2006-03-16 イーライ・リリー・アンド・カンパニー ステロイドホルモン核内レセプターモジュレーターとしてのジヒドロインドール−2−オン誘導体
TW200400816A (en) * 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators

Similar Documents

Publication Publication Date Title
CA2489276A1 (en) Tricyclic steroid hormone nuclear receptor modulators
CA2549053A1 (en) Tricyclic steroid hormone nuclear receptor modulators
ES2559687T3 (es) Composición y métodos para modular una cascada de cinasa
WO2024217557A1 (zh) 取代的四氢呋喃作为Nav1.8抑制剂
TWI445705B (zh) 經苯基及苯并二基取代之吲唑衍生物
JP6001771B2 (ja) mPGES−1阻害剤としてのトリアゾロン化合物
JP2007515413A5 (cg-RX-API-DMAC7.html)
Montagu et al. Synthesis of new C5-(1-substituted-1, 2, 3-triazol-4 or 5-yl)-2′-deoxyuridines and their antiviral evaluation
CA2519677A1 (en) Biaryl substituted 6-membered heterocycles as sodium channel blockers
TW200306838A (en) Chemical compounds
TW200927733A (en) Novel compounds and compositions and methods of use
JP2013545812A5 (cg-RX-API-DMAC7.html)
CA2755348A1 (en) Substituted aryl antiviral compounds and uses thereof
TW200306834A (en) Aminopyrimidine compound and pharmaceutical use thereof
CN1043231C (zh) (E)-α-去氧-α-(氟亚甲基)胞苷的一水合物
ES2929799T3 (es) Compuestos que contienen resto de 2-oxo-1,3,4-tiadiazinan-3-ilo con actividad agonista del receptor EP4
CN102250189A (zh) 一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物、其制备方法及医药用途
AU6491398A (en) Pyridazinones as inhibitors of cyclooxygenase-2
WO2018021520A1 (ja) グアニジン誘導体及びその医薬用途
CN111892636A (zh) 一种阿兹夫定的合成方法
JP2025148397A5 (cg-RX-API-DMAC7.html)
Tang et al. Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses
JP2010534670A5 (cg-RX-API-DMAC7.html)
CN110885318B (zh) 苯并恶唑衍生物及其制备方法和应用
TW200815362A (en) Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors